Advances in Chronic Kidney Disease

Papers
(The TQCC of Advances in Chronic Kidney Disease is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Medical Education During the Coronavirus Disease-2019 Pandemic: Learning From a Distance160
Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-1998
Proliferation of Papers and Preprints During the Coronavirus Disease 2019 Pandemic: Progress or Problems With Peer Review?40
Complement and the Kidney: An Overview26
VExUS Nexus: Bedside Assessment of Venous Congestion26
COVID-19 and Kidney Disease Disparities in the United States25
Targeting the Pathobiology of Diabetic Kidney Disease22
Inferior Vena Cava Collapsibility Index: Clinical Validation and Application for Assessment of Relative Intravascular Volume21
Renal Cell Cancer and Chronic Kidney Disease19
Home Dialysis in the Coronavirus Disease 2019 Era18
Conventional Chemotherapy Nephrotoxicity18
Kidney Physiology in Pregnancy18
COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management, and Operational Challenges17
C3 Glomerulopathy: Pathogenesis and Treatment17
Acute Kidney Injury in Pregnancy16
End-Stage Kidney Disease and Dialysis in Pregnancy15
Complement-Mediated Disorders in Pregnancy15
Policy and Pandemic: The Changing Practice of Nephrology During the Coronavirus Disease-2019 Outbreak15
Palliative Care in Nephrology: The Work and the Workforce15
A Cascade of Structural Barriers Contributing to Racial Kidney Transplant Inequities14
KDOQI 2019 Vascular Access Guidelines: What Is New?13
Tumor Lysis Syndrome13
Complement in IgA Nephropathy: The Role of Complement in the Pathogenesis, Diagnosis, and Future Management of IgA Nephropathy13
Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System13
Novel Anti-inflammatory and Anti-fibrotic Agents for Diabetic Kidney Disease—From Bench to Bedside12
Pregnancy in Kidney Transplant Recipients12
Current State of the Workforce in Nephrology12
Onco-hypertension: An Emerging Specialty11
An Introduction to Point-of-Care Ultrasound: Laennec to Lichtenstein11
Opportunities for Subspecialization in Nephrology11
Advances in Kidney Replacement Therapy in Infants11
The Nephrologist as an Ultrasonographer10
Complement-Based Therapy in the Management of Antibody-Mediated Rejection10
Artificial Intelligence in Acute Kidney Injury: From Static to Dynamic Models9
Continuous Kidney Replacement Therapy of the Future: Innovations in Information Technology, Data Analytics, and Quality Assurance Systems9
Chronic Kidney Disease and Pregnancy8
Management of Acute Kidney Injury in Coronavirus Disease 20198
Innovations to Increase Home Hemodialysis Utilization: The Transitional Care Unit8
Sexual Dysfunction in Women With Kidney Disease8
Overcoming Barriers to Implementing New Therapies for Diabetic Kidney Disease: Lessons Learned8
Therapeutic Plasma Exchange in the Critically Ill Patient: Technology and Indications8
Can Artificial Intelligence Assist in Delivering Continuous Renal Replacement Therapy?7
Machine Learning for Acute Kidney Injury Prediction in the Intensive Care Unit7
Urologic Considerations in Pediatric Chronic Kidney Disease7
Kidney Allocation Policy: Past, Present, and Future7
Deep Learning in Kidney Ultrasound: Overview, Frontiers, and Challenges6
Hypertensive Disorders of Pregnancy6
Thrombotic Microangiopathy Syndromes—Common Ground and Distinct Frontiers6
Breastfeeding and Medication Use in Kidney Disease6
Challenges of Vascular Access in the Pediatric Population6
Interventional Nephrology: Opportunities and Challenges6
Value-Based Care and Kidney Disease: Emergence and Future Opportunities6
Sodium-Glucose Cotransporter 2 Inhibition: Rationale and Mechanisms for Kidney and Cardiovascular Protection in People With and Without Diabetes6
Complement and Renal Thrombotic Microangiopathy Associated With Hypertension and Scleroderma6
Chronic Kidney Disease in Cancer Survivors5
Current Paradigms and Emerging Opportunities in Nephrology Training5
Glucagon-Like Peptide-1 Receptor Agonists—Use in Clinical Practice5
Immunotherapy-Related Acute Kidney Injury5
Glomerular Disease and Pregnancy5
Review of Clinical Disorders Causing Metabolic Acidosis5
COVID-19 Pandemic and Pregnancy in Kidney Disease5
Obesity Management in Kidney Transplant Candidates: Current Paradigms and Gaps in Knowledge5
Strategic Planning for Starting or Expanding a Home Hemodialysis Program5
Kidney Imaging and Biopsy in Pregnancy5
Cancer Screening in End-Stage Kidney Disease5
Point-of-Care Ultrasound in Acute Care Nephrology5
Late Kidney Effects of Childhood Cancer and Cancer Therapies5
Fluid Responsiveness in the Critically Ill Patient5
0.044498920440674